Stay up to date with the latest news and activities at AKESOgen.
AKESOgen, Inc. is pleased to announce that Dr. Hywel Jones has joined AKESOgen’s board of directors. Mr. Jones is currently the President and CEO of Singular Bio, Inc. Dr. Jones brings over 20 years of experience within the field of personalized medicine, molecular diagnostics, and platform technologies. He currently resides in San Francisco, CA.Share this
New York, Dec. 1st, 2010 – AKESOgen, today announced that it has been selected by British Airways as a 2010 Face-of-Opportunity winner and has been awarded travel to anywhere in the world to conduct vital business meetings as well as attend the British Airways Face-of-Opportunity business conference. This award is part of the British Airways Face-to-Face program, which provides small business owners and entrepreneurs the critical tools for building business relationships abroad and stimulating growth through the power of face- to-face interaction.
“We are thrilled to be part of the prestigious group of entrepreneurs that were chosen by British Airways as a Face-of-Opportunity winner,” said AKESOgen CEO Bob Boisjoli. “This flight will give us the chance to meet our key customers in 2011, which is vital for the growth of our business in 2011.”
Before taking off, AKESOgen will attend the British Airways Face-of-Opportunity conference in New York City on Feb. 2, 2011 where the company will receive free counsel from top influential international business experts while networking with venture capitalists, renowned entrepreneurs, media and other small business owners.
The conference, which includes an introduction by Simon Talling-Smith, Executive Vice President Americas, British Airways, and keynote speeches by Rhonda Abrams, best-selling author and USA Today small business columnist and Bill Rancic, best-selling author and first season winner of The Apprentice, will provide AKESOgen with additional tools in business planning, marketing and travel to assist the company in its strategy to enhance its mission in personalized medicine.
“We are very excited for this phase of the program and for the winning small business owners who, beyond the educational resources already provided through the Face-to-Face program, now have the opportunity to fly British Airways overseas to conduct vital face-to-face meetings for their business,” said Simon Talling-Smith. “Each of the winner’s stories is uniquely inspiring and our hope is that the program is a powerful catalyst in ensuring lasting and fruitful businesses for them.”
AKESOgen is a genomics Contract Research Organization that provides genomics and pharmacogenomics services to the academic, pharmaceutical, biotech and agricultural sectors.
About British Airways:
British Airways is one of the world’s largest international airlines. Operating one of the most extensive international scheduled airline route networks, together with its codeshare and franchise partners, the airline flies to more than 300 destinations worldwide. Also, one of the world’s longest established airlines, it has always been regarded as an industry-leader. British Airways flies its customers at convenient times to the best located airports across the world.
British Airways is one of the world’s leading global premium airlines with its principal place of business in London with significant presence at Heathrow, Gatwick and London City. It also operates a worldwide air cargo business, largely in conjunction with scheduled passenger services. The airline operates the majority of its domestic UK, international and intercontinental flights from its home at Terminal 5, Heathrow.
Whether customers are in the air or on the ground, British Airways takes pride in providing a full service experience.
Additional information on Face-to-Face is available by visiting the airlines website, ba.com/facetoface.
Jacquelyn Einaugler for British Airways
Text 100 Public Relations
– See more at: http://www.akesogen.com/?page=pr-2010-12-01#sthash.Ini8Z02b.dpufShare this
Read Genome Web’s Genome Technology ‘Clinical Focus Technical Guide‘ where Dr. Bouzyk shares advice on genomic sample preparation. Additionally, Dr. Bouzyk provides expert contributions for DNA isolation methodologies from FFPE for Genome Technology Magazine.Share this